Last reviewed · How we verify

NCT06635616

Hypertension Management in Terms of Routine Agents

Not yet recruiting Last updated 10 October 2024
What this trial tests

trial in Hypertension in 350 participants. Not yet recruiting.

Timeline
1 November 2024
Primary endpoint
1 November 2025
1 November 2025

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment350
Start date1 November 2024
Primary completion1 November 2025
Estimated completion1 November 2025
Sites2 locations across Turkey (Türkiye)

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

18 and older, any sex, with Hypertension or Emergency Medicine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

known hypertensive patients admitted to emergency department with increased blood pressure will be evaluated in terms of antihypertensive agents given at hospital, degree of blood pressure decrease, hospital stay and laboratory and imaging tests ordered. The impact of routine oral antihypertensive agents used by the patients on these parameter will be assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06635616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing